ID   DESPR_RAT               Reviewed;         127 AA.
AC   D3ZGZ6; Q6BDA5;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2013, sequence version 2.
DT   29-MAY-2024, entry version 58.
DE   RecName: Full=Dual endothelin-1/VEGF signal peptide receptor {ECO:0000250|UniProtKB:B0L3A2};
DE            Short=DEspR protein {ECO:0000250|UniProtKB:B0L3A2};
DE            Short=Dual endothelin-1/VEGFsp receptor {ECO:0000250|UniProtKB:B0L3A2};
DE   AltName: Full=Dual endothelin-1/angiotensin-2 receptor {ECO:0000303|PubMed:9508787};
DE            Short=Dear protein {ECO:0000303|PubMed:9508787};
DE   AltName: Full=FBXW7 antisense RNA 1 homolog {ECO:0000250|UniProtKB:B0L3A2};
GN   Name=Fbxw7-as1 {ECO:0000250|UniProtKB:B0L3A2};
GN   Synonyms=Dear {ECO:0000312|RGD:1303105};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF ARG-64 AND TRP-65.
RC   STRAIN=Sprague-Dawley {ECO:0000312|EMBL:AAT76519.1};
RC   TISSUE=Brain {ECO:0000303|PubMed:9508787};
RX   PubMed=9508787; DOI=10.1007/bf03401733;
RA   Ruiz-Opazo N., Hirayama K., Akimoto K., Herrera V.L.;
RT   "Molecular characterization of a dual endothelin-1/Angiotensin II
RT   receptor.";
RL   Mol. Med. 4:96-108(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   STRAIN=Dahl salt-resistant {ECO:0000303|PubMed:15561758}, and
RC   Dahl salt-sensitive {ECO:0000303|PubMed:15561758};
RX   PubMed=15561758; DOI=10.1152/physiolgenomics.00108.2004;
RA   Kaneko Y., Herrera V.L., Didishvili T., Ruiz-Opazo N.;
RT   "Sex-specific effects of dual ET-1/ANG II receptor (Dear) variants in Dahl
RT   salt-sensitive/resistant hypertension rat model.";
RL   Physiol. Genomics 20:157-164(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
CC   -!- FUNCTION: In the Dahl salt-resistant strain, acts as a dual receptor
CC       for both endothelin-1 and the signal sequence of vascular endothelial
CC       growth factor A and does not act as a receptor for angiotensin-2
CC       (PubMed:15561758). Does not bind the VEGFA mature protein (By
CC       similarity). In the Dahl salt-sensitive strain, acts as a dual
CC       endothelin-1/angiotensin-2 receptor that is functionally coupled to a
CC       calcium-mobilizing transduction system, responding equivalently to both
CC       endothelin-1/EDN1 and angiotensin-2 peptides in a highly specific
CC       manner (PubMed:15561758, PubMed:9508787). May play a role in
CC       angiogenesis with a significant role in cardiovascular and neural
CC       development (By similarity). {ECO:0000250|UniProtKB:B0L3A2,
CC       ECO:0000250|UniProtKB:Q2QKR2, ECO:0000269|PubMed:15561758,
CC       ECO:0000269|PubMed:9508787}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9508787};
CC       Single-pass membrane protein {ECO:0000250|UniProtKB:B0L3A2,
CC       ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Prominently expressed in brain and heart tissues.
CC       Weakly expressed in aorta, adrenal gland, and lung tissues.
CC       {ECO:0000269|PubMed:9508787}.
CC   -!- CAUTION: Acts as a dual endothelin-1/angiotensin-2 receptor only in the
CC       Dahl salt-sensitive strain (PubMed:15561758). In the Dahl salt-
CC       resistant strain and in other species including human and mouse,
CC       functions as a dual endothelin-1/VEGF signal peptide receptor and does
CC       not act as an angiotensin-2 receptor (PubMed:15561758).
CC       {ECO:0000269|PubMed:15561758}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY664492; AAT76519.1; -; mRNA.
DR   EMBL; AABR07012054; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001004448.2; NM_001004448.2.
DR   AlphaFoldDB; D3ZGZ6; -.
DR   PaxDb; 10116-ENSRNOP00000039897; -.
DR   Ensembl; ENSRNOT00000042146.5; ENSRNOP00000039897.3; ENSRNOG00000033147.5.
DR   GeneID; 446170; -.
DR   KEGG; rno:446170; -.
DR   AGR; RGD:1303105; -.
DR   CTD; 446170; -.
DR   RGD; 1303105; Dear.
DR   GeneTree; ENSGT00940000177316; -.
DR   HOGENOM; CLU_1969856_0_0_1; -.
DR   InParanoid; D3ZGZ6; -.
DR   PRO; PR:D3ZGZ6; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000033147; Expressed in frontal cortex.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0004945; F:angiotensin type II receptor activity; IMP:RGD.
DR   GO; GO:0004962; F:endothelin receptor activity; IMP:RGD.
DR   GO; GO:0038085; F:vascular endothelial growth factor binding; ISS:UniProtKB.
DR   GO; GO:0086100; P:endothelin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0038084; P:vascular endothelial growth factor signaling pathway; ISS:UniProtKB.
PE   1: Evidence at protein level;
KW   Cell membrane; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..127
FT                   /note="Dual endothelin-1/VEGF signal peptide receptor"
FT                   /id="PRO_0000454052"
FT   TOPO_DOM        1..69
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:B0L3A2"
FT   TRANSMEM        70..88
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        89..127
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:B0L3A2"
FT   VARIANT         44
FT                   /note="S -> P (in strain: Dahl salt-resistant)"
FT                   /evidence="ECO:0000269|PubMed:15561758"
FT   VARIANT         74
FT                   /note="M -> T (in strain: Dahl salt-resistant)"
FT                   /evidence="ECO:0000269|PubMed:15561758"
FT   MUTAGEN         64
FT                   /note="R->G: Abolishes binding with EDN1 without affecting
FT                   angiotensin-2 peptide binding."
FT                   /evidence="ECO:0000269|PubMed:9508787"
FT   MUTAGEN         65
FT                   /note="W->G: Abolishes binding with EDN1. Affects binding
FT                   with angiotensin-2 peptide."
FT                   /evidence="ECO:0000269|PubMed:9508787"
FT   CONFLICT        4
FT                   /note="F -> L (in Ref. 1; AAT76519)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   127 AA;  13733 MW;  C0D549CB6F61EF65 CRC64;
     MSTFYVTAVP KSHSSLPKCQ AMMSRTLLTG MAMYLDSSHA GAASMQVSWP PLLTSLGSKE
     MKSRWNWGSI TCIMCFTCVG SQLSMSSSKA SNFSGPLQLY QRGIGHITNP YRRPPAPAWP
     CSSSGTT
//
